Physician profile
Leon Telis
NPI 1740642727
$11,455.94
in general payments reported to CMS, 2019-2025
30 companies · $4,507 in 2025
The $4,507 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,548 · 2023: $2,250 · 2024: $2,150 · 2025: $4,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,829 · Travel and Lodging: $2,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,828.52 |
| Travel and Lodging | $2,079.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,349.01 | 2022-2025 | Titan |
| Boston Scientific Corporation | $3,103.99 | 2022-2025 | General - Erectile Dysfunction, Ams 700 Cxr Rte Kit, Ams 700 |
| Endo USA, INC. | $882.24 | 2024-2025 | Xiaflex, Aveed, Edex |
| Kerecis Limited | $578.96 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Urogen Pharma, INC. | $564.84 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $296.40 | 2022-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $151.36 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $143.53 | 2023-2024 | Aveed, Xiaflex, Edex |
| Teleflex LLC | $127.16 | 2023-2024 | Urolift |
| Blue Earth Diagnostics | $108.02 | 2023-2024 | |
| Abc Home Medical Supply, INC. | $107.39 | 2024-2025 | |
| Janssen Biotech, INC. | $102.26 | 2025 | Erleada |
| Tolmar, INC. | $95.61 | 2025 | Eligard |
| Sumitomo Pharma America, INC. | $92.29 | 2023-2025 | Orgovyx, Gemtesa |
| Becton, Dickinson and Company | $90.83 | 2025 | Bd Onclarity |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $90.52 | 2024-2025 | |
| Antares Pharma, INC. | $80.89 | 2024-2025 | Xyosted |
| Merck Sharp & Dohme LLC | $72.16 | 2024-2025 | Keytruda |
| Verity Pharmaceuticals INC. | $68.12 | 2024 | Trelstar, Tlando |
| Laborie Medical Technologies Corp. | $57.16 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $50.21 | 2025 | Xtandi |
| Civco Medical Instruments | $36.12 | 2024 | |
| Hollister Incorporated | $34.98 | 2023-2024 | Vapro, Infyna Chic, Vapro Pocket |
| Dentsply Ih Ab | $32.32 | 2025 | Lofric |
| Medtronic, INC. | $29.70 | 2025 | Interstim |
| Procept Biorobotics Corporation | $29.69 | 2025 | |
| Olympus America INC. | $22.06 | 2025 | Itind System |
| Profound Medical Corp. | $20.45 | 2025 | Tulsa-Pro |
| Myriad Genetic Laboratories, INC. | $19.34 | 2024 | Prolaris |
| Acerus Pharmaceuticals Corporation | $18.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Telis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.